P&T committee ranks 'influential'

Share this article:
Winning a place on formularies in the hospital marketplace may not require face time with a physician, research from Best Practices reveals.  

“We expect that hospitals' senior managers will take on a more important role in the eyes of the pharmaceutical sales force,” said Cameron Tew, senior manager, research and publishing at Best Practices. 

According to the study, pharmacy and therapeutic committee (P&T) members are the key formulary decision-makers for both hospital networks and local hospitals—not senior administrative staff such as CEOs and COOs.  “At this time, the cost and difficulty involved in targeting them outweighs their value as formulary influencers,” says Tew. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?